bell
The current prices are delayed by 15 mins, login to check live prices.
Hikal Ltd share price logo

Hikal Ltd

(HIKAL)

₹381.80.53%

as on 04:01PM, 07 Nov 2024

Overview
News
Financials
Q2 2024 Results
Technicals

Hikal Ltd Analyst Rating

based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts offering long term price targets for Hikal Ltd. An average target of ₹425

Source: S&P Global Market Intelligence

Hikal Ltd Share analysis

Hikal Ltd price forecast by 2 analysts

Upside of10.72%

High

₹430

Target

₹425.00

Low

₹420

Hikal Ltd target price ₹425, a slight upside of 10.72% compared to current price of ₹381.8. According to 2 analysts rating.

Source: S&P Global Market Intelligence

Hikal Ltd Performance

  • Day's Low

    Day's High

    ₹379.05
    ₹388.95
  • 52 Week's Low

    52 Week's High

    ₹260.3
    ₹410.9
1 Month Return+ 11.34 %
3 Month Return+ 19.08 %
1 Year Return+ 38.57 %
Previous Close₹383.85
Open₹383.85
Volume1.87L
Upper Circuit-
Lower Circuit-
Market Cap₹4,732.90Cr

Hikal Ltd Key Statistics

P/E Ratio69.79
PEG Ratio-32.77
Market Cap₹4,732.90 Cr
P/B Ratio2.75
EPS5.64
Dividend Yield0.45
SectorPharmaceuticals
ROE5.99

Hikal Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
BUY₹4,732.90 Cr46.58%0.72₹69 Cr₹1,784 Cr
HOLD₹33,703.13 Cr137.12%0.52₹300 Cr₹1,051 Cr
BUY₹19,854.36 Cr33.47%0.57₹72 Cr₹6,702 Cr
NA₹6,965.21 Cr6.09%0.79-₹388 Cr₹75 Cr
BUY₹15,940.57 Cr49.73%0.68₹218 Cr₹1,296 Cr

About Hikal Ltd

Hikal Limited is an Indian-based company, incorporated in 1988, with global recognition in the pharmaceutical, crop protection, animal health, biocides and specialty chemicals industries. It has 5 manufacturing facilities in 3 states, producing various chemical intermediates, active pharma ingredients, APIs and contract research activities. With their multiple partnerships and technological expansion projects, they have achieved milestones such as receiving the 5 Star Safety Award from the UK British Safety Council and their promotion to a trading house status. They have acquired an agrochemical manufacturing site from Novartis India Limited, which was followed by an investment in a JV with a Sinochem Corporation China subsidiary. Furthermore, they provide human and animal health products, amongst others. Recent developments such as the long-term contracts with life science companies, the sale of the RD unit and the bonus share issuance to shareholders indicate the company's success.

Share Price: ₹381.80 per share as on 07 Nov, 2024 04:01 PM
Market Capitalisation: ₹4,732.90Cr as of today
Revenue: ₹403.80Cr as on June 2024 (Q2 24)
Net Profit: ₹5.10Cr as on June 2024 (Q2 24)
Listing date: 14 Feb, 2001
Chairperson Name: Jai Hiremath
OrganisationHikal Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Hikal Ltd

  • Family Wealth Dispute Involving Hikal Ltd - 10 Oct, 2024

    Sugandha Hiremath alleges that her brother attempted to usurp the family's wealth and control over the company, leading to legal action in Pune court.

  • Hikal Ltd Faces Speculation Amid Family Dispute - 19 Sep, 2024

    Hikal Ltd's stability is questioned following Baba Kalyani's resignation as a non-executive director, linked to ongoing family disputes. ICRA notes operations remain stable but will monitor developments closely.

  • Hikal Shareholders Approve Board Reappointment - 18 Sep, 2024

    Hikal Ltd shareholders have approved the reappointment of Sugandha Hiremath to the board, with 50.6% votes in favor amid ongoing tensions between two promoter factions.

  • Hikal Shareholders Approve Reappointment of Director - 17 Sep, 2024

    Hikal shareholders approved the reappointment of Sugandha Hiremath despite opposition, with 56.87% votes in favor. Other resolutions, including interim dividend and appointing a new independent director, were also approved.

  • Hikal Ltd Control Transferred to Sugandha Hiremath - 16 Sep, 2024

    In a significant family dispute, control of Hikal Ltd has been given to Sugandha Hiremath, a director at the company, by her parents.

Insights on Hikal Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 2.73% to 3.22% in Sep 2024 quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 6.67% to 6.78% in Sep 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 128.4% return, outperforming this stock by 154.9%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 68.85% of holdings in Sep 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 71.0% return, outperforming this stock by 32.5%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 21.32% to 20.79% in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 514.7 Cr → 407.3 Cr (in ₹), with an average decrease of 20.9% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 33.9 Cr → 5.1 Cr (in ₹), with an average decrease of 85.0% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, HIKAL stock has moved down by -26.5%

Hikal Ltd Financials

Value in ₹ crore
DetailsQ'2 23Q'3 23Q'4 23Q'1 24Q'2 24
Revenue₹386.10Cr (-)₹431.23Cr (↑11.69%)₹438.54Cr (↑1.70%)₹512.80Cr (↑16.93%)₹403.80Cr (↓21.26%)
Net Income₹6.90Cr (-)₹12.57Cr (↑82.17%)₹16.14Cr (↑28.40%)₹33.90Cr (↑110.04%)₹5.10Cr (↓84.96%)
Net Profit Margin1.79% (-)2.91% (↑62.57%)3.68% (↑26.46%)6.61% (↑79.62%)1.26% (↓80.94%)
Value in ₹ crore
Details2021202220232024
Total Assets₹1,926.12Cr (-)₹2,213.12Cr (↑14.90%)₹2,400.52Cr (↑8.47%)₹2,504.30Cr (↑4.32%)
Total Liabilities₹992.70Cr (-)₹1,145.11Cr (↑15.35%)₹1,267.03Cr (↑10.65%)₹1,316.71Cr (↑3.92%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹284.93Cr (-)₹229.02Cr (↓19.62%)₹293.73Cr (↑28.26%)₹315.29Cr (↑7.34%)₹186.62Cr (↓40.81%)

Index Inclusions

BSE Healthcare

₹44,101.33

-0.85 (-377.93%)

BSE Small-Cap

₹55,764.08

-0.44 (-244.05%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

Hikal Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
68.85%
0.00
Foreign Institutions
6.78%
1.73
Mutual Funds
3.22%
17.85
Retail Investors
20.79%
-2.46
Others
0.36%
-17.97

Hikal Ltd Key Indicators

Details20202021202220232024
Return On Equity %12.0615.2216.047.125.99
Details20202021202220232024
Return On Assets %4.746.917.253.272.78
Details20202021202220232024
Book Value Per Share (₹)66.2275.786.6291.9396.32
Details20202021202220232024
Earning Per Share (₹)6.8510.813.026.365.64

Hikal Ltd Valuation

Hikal Ltd in the last 5 years

  • Overview

  • Trends

Lowest (8.33x)

March 24, 2020

Industry (57.15x)

November 6, 2024

Today (69.79x)

November 6, 2024

Highest (81.58x)

January 3, 2023

LowHigh

Hikal Ltd Earnings and Dividends

  • Hikal Ltd Earnings Results

    Hikal Ltd’s net profit fell -26.09% since last year same period to ₹5.10Cr in the Q1 2024-2025. On a quarterly growth basis, Hikal Ltd has generated -84.96% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Hikal Ltd Dividends May,2024

    In the quarter ending March 2024, Hikal Ltd has declared dividend of ₹0.60 - translating a dividend yield of 0.47%.

    Read More about Dividends

Hikal Ltd Technicals Summary

Bearish

Neutral

Bullish

Bullish

Hikal Ltd is currently in a Bullish trading position according to technical analysis indicators.

FAQs on Hikal Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Hikal Ltd shares.

Hikal Ltd (HIKAL) share price today is ₹381.8

Hikal Ltd is listed on NSE

Hikal Ltd is listed on BSE

  • Today’s highest price of Hikal Ltd is ₹388.95.
  • Today’s lowest price of Hikal Ltd is ₹379.05.

PE Ratio of Hikal Ltd is 69.79

PE ratio = Hikal Ltd Market price per share / Hikal Ltd Earnings per share

Today’s traded volume of Hikal Ltd(HIKAL) is 1.87L.

Today’s market capitalisation of Hikal Ltd(HIKAL) is ₹4732.9Cr.

Hikal Ltd(HIKALPrice
52 Week High
₹410.9
52 Week Low
₹260.3

Hikal Ltd(HIKAL) share price is ₹381.8. It is down -7.08% from its 52 Week High price of ₹410.9

Hikal Ltd(HIKAL) share price is ₹381.8. It is up 46.68% from its 52 Week Low price of ₹260.3

Hikal Ltd(HIKALReturns
1 Day Returns
-2.05%
1 Month Returns
11.34%
3 Month Returns
19.08%
1 Year Returns
38.57%